Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
359.15B
Market cap359.15B
Price-Earnings ratio
116.38
Price-Earnings ratio116.38
Dividend yield
2.34%
Dividend yield2.34%
Average volume
8.53M
Average volume8.53M
High today
$146.68
High today$146.68
Low today
$141.39
Low today$141.39
Open price
$141.39
Open price$141.39
Volume
9.29M
Volume9.29M
52 Week high
$156.92
52 Week high$156.92
52 Week low
$82.01
52 Week low$82.01

Stock Snapshot

With a market cap of 359.15B, Merck(MRK) trades at $146.31. The stock has a price-to-earnings ratio of 116.38 and currently yields dividends of 2.34%.

On 2026-10-11, Merck(MRK) stock traded between a low of $141.39 and a high of $146.68. Shares are currently priced at $146.31, which is +3.5% above the low and -0.3% below the high.

Merck(MRK) shares are trading with a volume of 9.29M, against a daily average of 8.53M.

During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.

During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.

MRK News

Benzinga 2d
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally

A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh investor interest in vaccine makers, sending several biotechnolog...

A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
24/7 Wall St. 2d
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Investing Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies Vaccine and biotechnology names are leading a sharp sector rally, and a smal...

Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
24/7 Wall St. 2d
Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

Investing Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVi...

Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
29%
Sell
3.2%

More MRK News

24/7 Wall St. 3d
HP, Merck, and Seagate Just Paid Their Shareholders. Here's What Landed in Their Accounts.

Investing HP, Merck, and Seagate Just Paid Their Shareholders. Here’s What Landed in Their Accounts. On October 7, three companies with nothing in common sent c...

HP, Merck, and Seagate Just Paid Their Shareholders. Here's What Landed in Their Accounts.
Investing.com 3d
Guggenheim reiterates Merck stock rating ahead of Q3 earnings - Investing.com

...

Guggenheim reiterates Merck stock rating ahead of Q3 earnings - Investing.com
Simply Wall St 4d
Merck, What Is Behind The Fresh Attention On The Drugmaker?

A Dutch court injunction blocking Merck (MRK) from manufacturing and selling subcutaneous Keytruda in eight European countries puts legal risk around a flagship...

Merck, What Is Behind The Fresh Attention On The Drugmaker?
TipRanks 4d
Tempus AI announces multi-year collaboration with Moderna, Merck

Tempus (TEM) announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene, a novel, potential first-in-clas...

TipRanks 4d
Halozyme announces Dutch court of the Hague found Merck infringed patents

Halozyme Therapeutics (HALO) announced that the specialized Dutch patent court of the Hague has found Merck (MRK) to be infringing one of its MDASE patents, EP...

Simply Wall St 5d
Will Drug Approvals Change Merck Narrative

Recent Merck news spans multiple therapeutic areas, including an FDA approval for WELIREG plus LENVIMA in advanced renal cell carcinoma, an FDA label update for...

Will Drug Approvals Change Merck Narrative
Zacks 5d
Merck Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Merck (MRK Quick QuoteMRK - Free Report) closed at $141.94, marking a +1.72% move from the previous day. The stock exceeded...

Merck Beats Stock Market Upswing: What Investors Need to Know

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.